Epimorphin is a novel regulator of the progesterone receptor isoform-A

Jamie L. Bascom, Derek C. Radisky, Eileen Koh, Jimmie E. Fata, Alvin Lo, Hidetoshi Mori, Neda Roosta, Yohei Hirai, Mina J. Bissell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Epimorphin/syntaxin-2 is a membrane-tethered protein localized extracellularly (Epim) and intracellularly (Stx-2). The extracellular form Epim stimulates morphogenic processes in a range of tissues, including in murine mammary glands where its overexpression in luminal epithelial cells is sufficient to drive hyperplasia and neoplasia. We analyzed WAP-Epim transgenic mice to gain insight into how Epim promotes malignancy. Ectopic overexpression of Epim during postnatal mammary gland development led to early side-branching onset, precocious bud formation, and increased proliferation of mammary epithelial cells. Conversely, peptide-based inhibition of Epim function reduced side branching. Because increased side branching and hyperplasia occurs similarly in mice upon overexpression of the progesterone receptor isoform-a (Pgr-a), we investigated whether Epim exhibits these phenotypes through Pgr modulation. Epim overexpression indeed led to a steep upregulation of both total Pgr mRNA and Pgr-a protein levels. Notably, the Pgr antagonist RU486 abrogated Epim-induced ductal side branching, mammary epithelial cell proliferation, and bud formation. Evaluation of Epim signaling in a three-dimensional ex vivo culture system showed that its action was dependent on binding to its extracellular receptor, integrin-aV, and on matrix metalloproteinase 3 activity downstream of Pgr-a. These findings elucidate a hitherto unknown transcriptional regulator of Pgr-a, and shed light on how overexpression of Epim leads to malignancy.

Original languageEnglish (US)
Pages (from-to)5917-5929
Number of pages13
JournalCancer Research
Volume73
Issue number18
DOIs
StatePublished - Sep 15 2013
Externally publishedYes

Fingerprint

Progesterone Receptors
Protein Isoforms
Epithelial Cells
Human Mammary Glands
Hyperplasia
Breast
Syntaxin 1
Matrix Metalloproteinase 3
Neoplasms
Integrins
Transgenic Mice
Membrane Proteins
Up-Regulation
Cell Proliferation
Phenotype
Messenger RNA
Peptides

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bascom, J. L., Radisky, D. C., Koh, E., Fata, J. E., Lo, A., Mori, H., ... Bissell, M. J. (2013). Epimorphin is a novel regulator of the progesterone receptor isoform-A. Cancer Research, 73(18), 5917-5929. https://doi.org/10.1158/0008-5472.CAN-13-0021

Epimorphin is a novel regulator of the progesterone receptor isoform-A. / Bascom, Jamie L.; Radisky, Derek C.; Koh, Eileen; Fata, Jimmie E.; Lo, Alvin; Mori, Hidetoshi; Roosta, Neda; Hirai, Yohei; Bissell, Mina J.

In: Cancer Research, Vol. 73, No. 18, 15.09.2013, p. 5917-5929.

Research output: Contribution to journalArticle

Bascom, JL, Radisky, DC, Koh, E, Fata, JE, Lo, A, Mori, H, Roosta, N, Hirai, Y & Bissell, MJ 2013, 'Epimorphin is a novel regulator of the progesterone receptor isoform-A', Cancer Research, vol. 73, no. 18, pp. 5917-5929. https://doi.org/10.1158/0008-5472.CAN-13-0021
Bascom, Jamie L. ; Radisky, Derek C. ; Koh, Eileen ; Fata, Jimmie E. ; Lo, Alvin ; Mori, Hidetoshi ; Roosta, Neda ; Hirai, Yohei ; Bissell, Mina J. / Epimorphin is a novel regulator of the progesterone receptor isoform-A. In: Cancer Research. 2013 ; Vol. 73, No. 18. pp. 5917-5929.
@article{f0f45a2e31f3452e89e778321f788776,
title = "Epimorphin is a novel regulator of the progesterone receptor isoform-A",
abstract = "Epimorphin/syntaxin-2 is a membrane-tethered protein localized extracellularly (Epim) and intracellularly (Stx-2). The extracellular form Epim stimulates morphogenic processes in a range of tissues, including in murine mammary glands where its overexpression in luminal epithelial cells is sufficient to drive hyperplasia and neoplasia. We analyzed WAP-Epim transgenic mice to gain insight into how Epim promotes malignancy. Ectopic overexpression of Epim during postnatal mammary gland development led to early side-branching onset, precocious bud formation, and increased proliferation of mammary epithelial cells. Conversely, peptide-based inhibition of Epim function reduced side branching. Because increased side branching and hyperplasia occurs similarly in mice upon overexpression of the progesterone receptor isoform-a (Pgr-a), we investigated whether Epim exhibits these phenotypes through Pgr modulation. Epim overexpression indeed led to a steep upregulation of both total Pgr mRNA and Pgr-a protein levels. Notably, the Pgr antagonist RU486 abrogated Epim-induced ductal side branching, mammary epithelial cell proliferation, and bud formation. Evaluation of Epim signaling in a three-dimensional ex vivo culture system showed that its action was dependent on binding to its extracellular receptor, integrin-aV, and on matrix metalloproteinase 3 activity downstream of Pgr-a. These findings elucidate a hitherto unknown transcriptional regulator of Pgr-a, and shed light on how overexpression of Epim leads to malignancy.",
author = "Bascom, {Jamie L.} and Radisky, {Derek C.} and Eileen Koh and Fata, {Jimmie E.} and Alvin Lo and Hidetoshi Mori and Neda Roosta and Yohei Hirai and Bissell, {Mina J.}",
year = "2013",
month = "9",
day = "15",
doi = "10.1158/0008-5472.CAN-13-0021",
language = "English (US)",
volume = "73",
pages = "5917--5929",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Epimorphin is a novel regulator of the progesterone receptor isoform-A

AU - Bascom, Jamie L.

AU - Radisky, Derek C.

AU - Koh, Eileen

AU - Fata, Jimmie E.

AU - Lo, Alvin

AU - Mori, Hidetoshi

AU - Roosta, Neda

AU - Hirai, Yohei

AU - Bissell, Mina J.

PY - 2013/9/15

Y1 - 2013/9/15

N2 - Epimorphin/syntaxin-2 is a membrane-tethered protein localized extracellularly (Epim) and intracellularly (Stx-2). The extracellular form Epim stimulates morphogenic processes in a range of tissues, including in murine mammary glands where its overexpression in luminal epithelial cells is sufficient to drive hyperplasia and neoplasia. We analyzed WAP-Epim transgenic mice to gain insight into how Epim promotes malignancy. Ectopic overexpression of Epim during postnatal mammary gland development led to early side-branching onset, precocious bud formation, and increased proliferation of mammary epithelial cells. Conversely, peptide-based inhibition of Epim function reduced side branching. Because increased side branching and hyperplasia occurs similarly in mice upon overexpression of the progesterone receptor isoform-a (Pgr-a), we investigated whether Epim exhibits these phenotypes through Pgr modulation. Epim overexpression indeed led to a steep upregulation of both total Pgr mRNA and Pgr-a protein levels. Notably, the Pgr antagonist RU486 abrogated Epim-induced ductal side branching, mammary epithelial cell proliferation, and bud formation. Evaluation of Epim signaling in a three-dimensional ex vivo culture system showed that its action was dependent on binding to its extracellular receptor, integrin-aV, and on matrix metalloproteinase 3 activity downstream of Pgr-a. These findings elucidate a hitherto unknown transcriptional regulator of Pgr-a, and shed light on how overexpression of Epim leads to malignancy.

AB - Epimorphin/syntaxin-2 is a membrane-tethered protein localized extracellularly (Epim) and intracellularly (Stx-2). The extracellular form Epim stimulates morphogenic processes in a range of tissues, including in murine mammary glands where its overexpression in luminal epithelial cells is sufficient to drive hyperplasia and neoplasia. We analyzed WAP-Epim transgenic mice to gain insight into how Epim promotes malignancy. Ectopic overexpression of Epim during postnatal mammary gland development led to early side-branching onset, precocious bud formation, and increased proliferation of mammary epithelial cells. Conversely, peptide-based inhibition of Epim function reduced side branching. Because increased side branching and hyperplasia occurs similarly in mice upon overexpression of the progesterone receptor isoform-a (Pgr-a), we investigated whether Epim exhibits these phenotypes through Pgr modulation. Epim overexpression indeed led to a steep upregulation of both total Pgr mRNA and Pgr-a protein levels. Notably, the Pgr antagonist RU486 abrogated Epim-induced ductal side branching, mammary epithelial cell proliferation, and bud formation. Evaluation of Epim signaling in a three-dimensional ex vivo culture system showed that its action was dependent on binding to its extracellular receptor, integrin-aV, and on matrix metalloproteinase 3 activity downstream of Pgr-a. These findings elucidate a hitherto unknown transcriptional regulator of Pgr-a, and shed light on how overexpression of Epim leads to malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84884786652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884786652&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-0021

DO - 10.1158/0008-5472.CAN-13-0021

M3 - Article

C2 - 23867473

AN - SCOPUS:84884786652

VL - 73

SP - 5917

EP - 5929

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 18

ER -